vs

Side-by-side financial comparison of PERDOCEO EDUCATION Corp (PRDO) and Rocket Lab Corp (RKLB). Click either name above to swap in a different company.

PERDOCEO EDUCATION Corp is the larger business by last-quarter revenue ($211.6M vs $179.7M, roughly 1.2× Rocket Lab Corp). On growth, Rocket Lab Corp posted the faster year-over-year revenue change (35.7% vs 20.0%). PERDOCEO EDUCATION Corp produced more free cash flow last quarter ($37.9M vs $-114.2M). Over the past eight quarters, Rocket Lab Corp's revenue compounded faster (39.2% CAGR vs 12.2%).

Perdoceo Education Corporation (PRDO) is a public company that owns five for-profit universities in the United States: American Intercontinental University, Colorado Technical University, California Southern University, Trident University International, and University of St. Augustine for Health Sciences. The company was previously known as Career Education Corporation.

Rocket Lab Corporation is a publicly traded aerospace manufacturer and launch service provider. Its Electron orbital rocket launches small satellites and has successfully completed over 75 missions as of January 2026, making it the most prolific small-lift launch vehicle in operation globally. A suborbital variant of Electron, called HASTE, was developed as a testbed to advance hypersonic technology development, while the next-generation reusable Neutron medium-lift launch vehicle is in devel...

PRDO vs RKLB — Head-to-Head

Bigger by revenue
PRDO
PRDO
1.2× larger
PRDO
$211.6M
$179.7M
RKLB
Growing faster (revenue YoY)
RKLB
RKLB
+15.7% gap
RKLB
35.7%
20.0%
PRDO
More free cash flow
PRDO
PRDO
$152.1M more FCF
PRDO
$37.9M
$-114.2M
RKLB
Faster 2-yr revenue CAGR
RKLB
RKLB
Annualised
RKLB
39.2%
12.2%
PRDO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PRDO
PRDO
RKLB
RKLB
Revenue
$211.6M
$179.7M
Net Profit
$-52.9M
Gross Margin
38.0%
Operating Margin
19.8%
-28.4%
Net Margin
-29.5%
Revenue YoY
20.0%
35.7%
Net Profit YoY
-1.1%
EPS (diluted)
$0.55
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRDO
PRDO
RKLB
RKLB
Q4 25
$211.6M
$179.7M
Q3 25
$211.9M
$155.1M
Q2 25
$209.6M
$144.5M
Q1 25
$213.0M
$122.6M
Q4 24
$176.4M
$132.4M
Q3 24
$169.8M
$104.8M
Q2 24
$166.7M
$106.3M
Q1 24
$168.3M
$92.8M
Net Profit
PRDO
PRDO
RKLB
RKLB
Q4 25
$-52.9M
Q3 25
$39.9M
$-18.3M
Q2 25
$41.0M
$-66.4M
Q1 25
$43.7M
$-60.6M
Q4 24
$-52.3M
Q3 24
$38.3M
$-51.9M
Q2 24
$38.4M
$-41.6M
Q1 24
$39.4M
$-44.3M
Gross Margin
PRDO
PRDO
RKLB
RKLB
Q4 25
38.0%
Q3 25
37.0%
Q2 25
32.1%
Q1 25
28.8%
Q4 24
27.8%
Q3 24
26.7%
Q2 24
25.6%
Q1 24
26.1%
Operating Margin
PRDO
PRDO
RKLB
RKLB
Q4 25
19.8%
-28.4%
Q3 25
24.1%
-38.0%
Q2 25
24.5%
-41.3%
Q1 25
24.3%
-48.3%
Q4 24
21.1%
-38.9%
Q3 24
26.4%
-49.5%
Q2 24
27.6%
-40.7%
Q1 24
27.5%
-46.4%
Net Margin
PRDO
PRDO
RKLB
RKLB
Q4 25
-29.5%
Q3 25
18.8%
-11.8%
Q2 25
19.6%
-46.0%
Q1 25
20.5%
-49.5%
Q4 24
-39.5%
Q3 24
22.5%
-49.6%
Q2 24
23.0%
-39.2%
Q1 24
23.4%
-47.7%
EPS (diluted)
PRDO
PRDO
RKLB
RKLB
Q4 25
$0.55
$-0.09
Q3 25
$0.60
$-0.03
Q2 25
$0.62
$-0.13
Q1 25
$0.65
$-0.12
Q4 24
$0.46
$-0.11
Q3 24
$0.57
$-0.10
Q2 24
$0.57
$-0.08
Q1 24
$0.59
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRDO
PRDO
RKLB
RKLB
Cash + ST InvestmentsLiquidity on hand
$111.0M
$1.0B
Total DebtLower is stronger
$152.4M
Stockholders' EquityBook value
$972.4M
$1.7B
Total Assets
$1.2B
$2.3B
Debt / EquityLower = less leverage
0.09×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRDO
PRDO
RKLB
RKLB
Q4 25
$111.0M
$1.0B
Q3 25
$159.5M
$976.7M
Q2 25
$172.1M
$688.1M
Q1 25
$132.1M
$428.4M
Q4 24
$109.1M
$419.0M
Q3 24
$238.0M
$442.4M
Q2 24
$127.9M
$496.8M
Q1 24
$125.8M
$492.5M
Total Debt
PRDO
PRDO
RKLB
RKLB
Q4 25
$152.4M
Q3 25
$347.0M
Q2 25
$346.5M
Q1 25
$345.9M
Q4 24
$345.4M
Q3 24
$61.2M
Q2 24
$64.2M
Q1 24
$66.8M
Stockholders' Equity
PRDO
PRDO
RKLB
RKLB
Q4 25
$972.4M
$1.7B
Q3 25
$997.9M
$1.3B
Q2 25
$984.6M
$688.5M
Q1 25
$970.3M
$431.3M
Q4 24
$959.5M
$382.5M
Q3 24
$935.4M
$419.8M
Q2 24
$899.5M
$455.2M
Q1 24
$866.1M
$478.9M
Total Assets
PRDO
PRDO
RKLB
RKLB
Q4 25
$1.2B
$2.3B
Q3 25
$1.3B
$2.2B
Q2 25
$1.3B
$1.6B
Q1 25
$1.3B
$1.3B
Q4 24
$1.2B
$1.2B
Q3 24
$1.1B
$1.2B
Q2 24
$1.1B
$1.2B
Q1 24
$1.1B
$1.2B
Debt / Equity
PRDO
PRDO
RKLB
RKLB
Q4 25
0.09×
Q3 25
0.27×
Q2 25
0.50×
Q1 25
0.80×
Q4 24
0.90×
Q3 24
0.15×
Q2 24
0.14×
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRDO
PRDO
RKLB
RKLB
Operating Cash FlowLast quarter
$40.1M
$-64.5M
Free Cash FlowOCF − Capex
$37.9M
$-114.2M
FCF MarginFCF / Revenue
17.9%
-63.6%
Capex IntensityCapex / Revenue
1.1%
27.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$216.7M
$-321.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRDO
PRDO
RKLB
RKLB
Q4 25
$40.1M
$-64.5M
Q3 25
$41.2M
$-23.5M
Q2 25
$78.8M
$-23.2M
Q1 25
$65.1M
$-54.2M
Q4 24
$17.6M
$-2.4M
Q3 24
$51.0M
$-30.9M
Q2 24
$38.5M
$-13.0M
Q1 24
$54.5M
$-2.6M
Free Cash Flow
PRDO
PRDO
RKLB
RKLB
Q4 25
$37.9M
$-114.2M
Q3 25
$39.4M
$-69.4M
Q2 25
$76.0M
$-55.3M
Q1 25
$63.4M
$-82.9M
Q4 24
$16.0M
$-23.9M
Q3 24
$50.0M
$-41.9M
Q2 24
$37.7M
$-28.3M
Q1 24
$53.3M
$-21.8M
FCF Margin
PRDO
PRDO
RKLB
RKLB
Q4 25
17.9%
-63.6%
Q3 25
18.6%
-44.8%
Q2 25
36.3%
-38.3%
Q1 25
29.8%
-67.6%
Q4 24
9.1%
-18.1%
Q3 24
29.4%
-40.0%
Q2 24
22.6%
-26.7%
Q1 24
31.7%
-23.5%
Capex Intensity
PRDO
PRDO
RKLB
RKLB
Q4 25
1.1%
27.6%
Q3 25
0.9%
29.6%
Q2 25
1.3%
22.2%
Q1 25
0.8%
23.4%
Q4 24
0.9%
16.3%
Q3 24
0.6%
10.5%
Q2 24
0.5%
14.4%
Q1 24
0.7%
20.7%
Cash Conversion
PRDO
PRDO
RKLB
RKLB
Q4 25
Q3 25
1.03×
Q2 25
1.92×
Q1 25
1.49×
Q4 24
Q3 24
1.33×
Q2 24
1.00×
Q1 24
1.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRDO
PRDO

CTU$107.0M51%
AIUS$60.8M29%
University Of St Augustine For Health Sciences Llc$43.7M21%
Other$1.1M1%

RKLB
RKLB

Products$94.0M52%
Transferred Over Time$87.3M49%

Related Comparisons